Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with 18F-FDG PET, Journal of Nuclear Medicine, vol.50, issue.10, pp.1598-1604, 2009. ,
DOI : 10.2967/jnumed.108.060145
Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging, Cancer Research, vol.65, issue.13, pp.5907-5916, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-4472
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies, Cancer Res, vol.61, pp.3712-3729, 2001. ,
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging, Journal of Nuclear Medicine, vol.50, issue.6, pp.974-981, 2009. ,
DOI : 10.2967/jnumed.108.060392
Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules, Journal of Nuclear Medicine, vol.51, issue.6, pp.892-897, 2010. ,
DOI : 10.2967/jnumed.109.073239
Impact of Triple Negative Phenotype on Breast Cancer Prognosis, The Breast Journal, vol.7, issue.5, pp.456-63, 2008. ,
DOI : 10.1111/j.1524-4741.2008.00622.x
ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model, Journal of Nuclear Medicine, vol.51, issue.10, pp.1565-1572, 2010. ,
DOI : 10.2967/jnumed.110.075648
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors, EJNMMI Research, vol.1, issue.1, p.20, 2011. ,
DOI : 10.1016/j.ejca.2004.01.038
URL : https://hal.archives-ouvertes.fr/inserm-00626326
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA- trastuzumab PET, J Nucl Med, vol.55, issue.1, pp.201423-201432 ,